Biphasic effects of 17‐β‐estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells
- 10 June 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 196 (2) , 362-369
- https://doi.org/10.1002/jcp.10315
Abstract
Tight junctions govern the paracellular permeability of endothelial and epithelial cells. Aberrations of tight junction function are an early and key event during the vascular spread of cancer and inflammation. This study sought to determine the role of estrogen in the regulation of tight junctions and expression of molecules making tight junctions in endothelial cells. Human endothelial cell, HECV, which express ER-β but not ER-α was used. 17-β-estradiol induced a concentration- and time-dependent biphasic effect on tight junction. At 10−9 and 10−6 M, it decreased the level of occludin and increased in paracellular permeability of HECV cells, but at 10−12 M it decreased in paracellular permeability and increased the level of occludin. The transendothelial electrical resistance (TER), however, was reduced by 17-β-estradiol at lower concentrations (as low as 10−12 M). Furthermore, the time-dependent biphasic effect was observed over a period of 4 days, with the first reduction of TER seen within 15 min and the second drop occurring 48 h after 17-β-estradiol treatment. It was further revealed that protein and mRNA levels of occludin, but not claudin-1 and -5, and ZO-1, were reduced by 17-β-estradiol, in line with changes of TER. This study shows that 17-β-estradiol can induce concentration- and time-related biphasic effects on tight junction functions expression of occludin in endothelial cells and that this perturbation of tight junction functions may have implications in the etiology of mastalgia and the vascular spread of breast cancer. J. Cell. Physiol. 196: 362–369, 2003.Keywords
This publication has 31 references indexed in Scilit:
- Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cellsJournal of Cellular Physiology, 2002
- Expression and targeting of the tight junction protein CLDN1 in CLDN1‐negative human breast tumor cellsJournal of Cellular Physiology, 2002
- Transforming Growth Factor-α Abrogates the Glucocorticoid Stimulation of Tight Junction Formation and Reverses the Steroid-Induced Down-regulation of Fascin in Rat Mammary Epithelial Tumor Cells by a Ras-Dependent PathwayExperimental Cell Research, 2002
- Down‐regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type‐1 receptor and nuclear factor‐κB activationJournal of Neurochemistry, 2001
- Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancerCritical Reviews in Oncology/Hematology, 1999
- Regulation of Tight Junction Permeability and Occludin Expression by Polyunsaturated Fatty AcidsBiochemical and Biophysical Research Communications, 1998
- Localization of 7H6 Tight Junction-Associated Antigen along the Cell Border of Vascular Endothelial Cells Correlates with Paracellular Barrier Function against Ions, Large Molecules, and Cancer CellsExperimental Cell Research, 1996
- Molecular Dissection of Tight Junctions.Cell Structure and Function, 1996
- The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growthNature, 1994
- Occludin: a novel integral membrane protein localizing at tight junctions.The Journal of cell biology, 1993